Donald Trump’s brokerage accounts made a string of well-timed stock purchases in his first year back in the White House, including a stake in the Taser maker now in line to arm his ICE deportation force, financial disclosures show. 

The President bought into some of the most familiar names on Wall Street, among them the tech giants of the so-called Magnificent Seven.

Trump’s biggest spree came on August 18, when he made three back-to-back buys of Apple, Microsoft and Nvidia worth between $5 million and $25 million each.

He also bought Amazon stock in September, the same day a federal trial opened over claims the company duped customers into paying for Prime. Amazon settled two days later for a $1 billion penalty and $1.5 billion in customer refunds. 

But it is one of Trump’s more niche trades that is now drawing the sharpest scrutiny.

Trump’s trust bought between $1 million and $5 million in Axon Enterprise, the company behind the Taser, on February 10, according to disclosures filed in May and first reported by CNBC this week.

ICE posted a notice two weeks later seeking roughly 17,800 new stun guns plus unlimited cartridges and training, a five-year deal valued at $220 million.

The notice does not name Axon. Its specifications, including a 45ft range and 10 individually deployable probes, track the company’s Taser 10, procurement reviewers and three policing experts told CNBC.

President Donald Trump speaks to the press before he boards Air Force One for his first flight aboard the Boeing 747-8 that Qatar gifted the United States to use for executive travel, at Joint Base Andrews, in Maryland, July 1

The Wall Street Bull in Manhattan, New York

Those requirements would effectively rule out every other bidder, the experts said. Axon makes roughly 90 percent of the Tasers used in the US.

The contract would more than quadruple ICE’s supply, replacing about 4,300 devices already in the field. It has not been awarded.

Axon shares closed at 560.61 on June 30, up about 29 per cent from the 434.45 they were trading at when Trump’s account bought in on February 10.

There is no evidence Trump directed the trade, knew about the ICE procurement or that Axon knew he held a stake. 

The trades run through discretionary accounts at firms including Charles Schwab and JPMorgan Chase, with Donald Trump Jr acting as trustee.

Under that arrangement the brokerages hold sole authority to buy and sell, and are barred from taking trade requests from the President or his family.

Unlike every president since the 1970s to hold individual stocks, Trump has not placed his assets in a blind trust, meaning he can see what he owns even though he cannot direct the trading himself.

The White House points to that trust structure as proof of separation, saying investments are handled by independent third-party firms rather than the President or his family. 

‘There are no conflicts of interest,’ White House spokeswoman Anna Kelly told CNBC, branding the scrutiny a ‘tired narrative’ from Democrats. 

Presidents are exempt from the criminal conflict-of-interest law that binds other executive-branch officials.

The STOCK Act requires disclosure of individual trades but does not bar them.

Axon already holds a $370 million DHS body-camera and software contract awarded in 2023.

Its revenue hit record highs through 2025 and early 2026, driven by Taser sales.

The company spent about $2.5 million on lobbying in 2025, its highest annual total, and hired a former Palantir executive to build out its federal business.

The current ICE Taser contract lapses on August 21. 

The Daily Mail has contacted the White House for comment.